Key statistics
On Friday, Rezolute Inc (6HV1:MUN) closed at 2.42, 106.84% above the 52 week low of 1.17 set on Dec 12, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.40 |
|---|---|
| High | 2.42 |
| Low | 2.40 |
| Bid | 2.60 |
| Offer | 2.72 |
| Previous close | 2.46 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 92.73m |
| Free float | 82.97m |
| P/E (TTM) | -- |
| Market cap | 270.76m USD |
| EPS (TTM) | -0.9291 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 08:05 GMT.
More ▼
Announcements
- Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
- Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
- Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
- Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
- Rezolute to Host Virtual Investor Event on Ersodetug Development Program
- Rezolute to Participate in Upcoming Investor Conferences
- Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
- Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
More ▼
